260 related articles for article (PubMed ID: 26392417)
1. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
[TBL] [Abstract][Full Text] [Related]
2. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
[TBL] [Abstract][Full Text] [Related]
3. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
[TBL] [Abstract][Full Text] [Related]
4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
5. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
Khaitan D; Dinger ME; Mazar J; Crawford J; Smith MA; Mattick JS; Perera RJ
Cancer Res; 2011 Jun; 71(11):3852-62. PubMed ID: 21558391
[TBL] [Abstract][Full Text] [Related]
6. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation.
Ma J; Tang X; Wong P; Jacobs B; Borden EC; Bedogni B
J Biol Chem; 2014 Mar; 289(12):8442-9. PubMed ID: 24492617
[TBL] [Abstract][Full Text] [Related]
8. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
Thakur V; Bedogni B
Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
[TBL] [Abstract][Full Text] [Related]
9. The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.
Bartolomé RA; Ferreiro S; Miquilena-Colina ME; Martínez-Prats L; Soto-Montenegro ML; García-Bernal D; Vaquero JJ; Agami R; Delgado R; Desco M; Sánchez-Mateos P; Teixidó J
Am J Pathol; 2009 Feb; 174(2):602-12. PubMed ID: 19147814
[TBL] [Abstract][Full Text] [Related]
10. Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion.
Tatti O; Arjama M; Ranki A; Weiss SJ; Keski-Oja J; Lehti K
PLoS One; 2011; 6(12):e28325. PubMed ID: 22164270
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
12. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
13. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
[TBL] [Abstract][Full Text] [Related]
14. High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells.
Tomari T; Koshikawa N; Uematsu T; Shinkawa T; Hoshino D; Egawa N; Isobe T; Seiki M
Cancer Sci; 2009 Jul; 100(7):1284-90. PubMed ID: 19432894
[TBL] [Abstract][Full Text] [Related]
15. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.
Petrella BL; Brinckerhoff CE
Mol Cancer; 2006 Dec; 5():66. PubMed ID: 17140440
[TBL] [Abstract][Full Text] [Related]
17. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
[TBL] [Abstract][Full Text] [Related]
18. Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A.
Desch A; Strozyk EA; Bauer AT; Huck V; Niemeyer V; Wieland T; Schneider SW
Am J Pathol; 2012 Aug; 181(2):693-705. PubMed ID: 22659470
[TBL] [Abstract][Full Text] [Related]
19. Membrane-type 1 matrix metalloproteinase regulates cell migration during zebrafish gastrulation: evidence for an interaction with non-canonical Wnt signaling.
Coyle RC; Latimer A; Jessen JR
Exp Cell Res; 2008 Jun; 314(10):2150-62. PubMed ID: 18423448
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
